Clinical efficacy of Daikenchuto (DKT: TJ-100) for gastrointestinal dysfunction following resection of liver cancer (a randomized, double-blind, multi-center, placebo-controlled study)
Latest Information Update: 21 Feb 2018
At a glance
- Drugs TU 100 (Primary)
- Indications Liver cancer
- Focus Pharmacodynamics; Therapeutic Use
- 20 Jan 2018 Results of a pooled retrospective subset analysis from 39-0902, 40-1001, and 42-1002 trials presented at the 2018 Gastrointestinal Cancers Symposium
- 02 Mar 2017 New trial record
- 24 Feb 2017 A pooled analysis of three randomized controlled trials (UMIN000001592, UMIN000003103 and UMIN000004693) is being conducted and is registered in UMIN (UMIN000026292, Daikenchuto for enhancement of bowel movement after open abdominal surgery: a pooled analysis of three randomized controlled trials) with primary endpoint 'the time from the first meal after extubation to the first evacuation'.